BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18486889)

  • 1. Sentinel lymph node biopsy in breast cancer.
    Fortunato L; Mascaro A; Amini M; Farina M; Vitelli CE
    Surg Oncol Clin N Am; 2008 Jul; 17(3):673-99, x. PubMed ID: 18486889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in sentinel lymph node biopsy for breast cancer.
    Goyal A; Mansel RE
    Curr Opin Oncol; 2008 Nov; 20(6):621-6. PubMed ID: 18841040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal access breast surgery: a single breast incision for breast conservation surgery and sentinel lymph node biopsy.
    Spillane AJ; Brennan ME
    Eur J Surg Oncol; 2009 Apr; 35(4):380-6. PubMed ID: 18757165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of sentinel lymph node biopsy in the management of breast cancer.
    Khan A; Vohra P; Quinlan RF
    Indian J Pathol Microbiol; 2007 Apr; 50(2):261-9. PubMed ID: 17883042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel node mapping for breast cancer: progress to date and prospects for the future.
    Mabry H; Giuliano AE
    Surg Oncol Clin N Am; 2007 Jan; 16(1):55-70. PubMed ID: 17336236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Limitations of sentinel lymph node biopsy in breast cancer].
    Fehr MK
    Gynakol Geburtshilfliche Rundsch; 2005 Jun; 45(3):127-31. PubMed ID: 15990436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A decade of sentinel lymph node biopsy for breast cancer: time for adaptations].
    Wobbes T
    Ned Tijdschr Geneeskd; 2008 Jan; 152(1):10-2. PubMed ID: 18240753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage migration due to introduction of the sentinel node procedure: a population-based study.
    Maaskant AJ; van de Poll-Franse LV; Voogd AC; Coebergh JW; Tutein Nolthenius-Puylaert MC; Nieuwenhuijzen GA
    Breast Cancer Res Treat; 2009 Jan; 113(1):173-9. PubMed ID: 18259855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast sentinel lymph node dissection before preoperative chemotherapy.
    Grube BJ; Christy CJ; Black D; Martel M; Harris L; Weidhaas J; Digiovanna MP; Chung G; Abu-Khalaf MM; Miller KD; Higgins SA; Philpotts L; Tavassoli FA; Lannin DR
    Arch Surg; 2008 Jul; 143(7):692-9; discussion 699-700. PubMed ID: 18645113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ.
    Dominguez FJ; Golshan M; Black DM; Hughes KS; Gadd MA; Christian R; Lesnikoski BA; Specht M; Michaelson J; Smith BL
    Ann Surg Oncol; 2008 Jan; 15(1):268-73. PubMed ID: 17891441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance and management of micrometastases in patients with breast cancer.
    Mittendorf EA; Hunt KK
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1451-61. PubMed ID: 17944569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
    Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
    Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of the sentinel lymph nodes status in breast carcinoma using microscopic, immunohistochemical and cytomorphometric methods in order to establish new stadializations and therapeutic schemes.
    Stolnicu S; Coros MF; Podeanu DM; Carata E; Mezei T; Muscă S; Podoleanu C; Rădulescu D
    Rom J Morphol Embryol; 2009; 50(1):51-60. PubMed ID: 19221645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node biopsy after neoadjuvant systemic chemotherapy in patients with breast cancer: a prospective pilot trial.
    Medina-Franco H; Salgado-Nesme N; Zerón-Medina-Cuairán J
    Rev Invest Clin; 2008; 60(5):390-4. PubMed ID: 19227436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Micrometastatic disease and residual axillary disease. Breast cancer as an example Alct].
    Penault-Llorca F; Mishellany F
    Cancer Radiother; 2006 Nov; 10(6-7):338-42. PubMed ID: 16973394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microinvasive breast cancer and the role of sentinel node biopsy: an institutional experience and review of the literature.
    Guth AA; Mercado C; Roses DF; Darvishian F; Singh B; Cangiarella JF
    Breast J; 2008; 14(4):335-9. PubMed ID: 18537917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular assessment of sentinel lymph node in breast cancer management.
    Douglas-Jones AG; Woods V
    Histopathology; 2009 Jul; 55(1):107-13. PubMed ID: 19469912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant induction chemotherapy.
    Schwartz G
    Minerva Ginecol; 2005 Jun; 57(3):327-48. PubMed ID: 16166939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.